Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (331-340 of 357) with videos related to

Pageof 36
Sort By:
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1sJeremy M Travins, Farah Ali, Hui Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Ehab Khalil, Jeremy M Travins, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
Pageof 36

Showing results (331-340 of 357) with videos related to

Sort By:
Pageof 36
The Prostate|July 26, 2018
Germline mutations in PPFIBP2 are associated with lethal prostate cancerYishuo Wu, Hongjie Yu, Siqun Lilly Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1sJeremy M Travins, Farah Ali, Hui Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Ehab Khalil, Jeremy M Travins, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
Pageof 36